What 'healthy fats' actually are — and how to choose the right ones for your diet
Protein, dairy, and so-called "healthy" fats are the foundational elements of the new dietary guidelines. But what is a "healthy" fat, anyway?
Read Full SynopsisStay updated with the latest research, trends, and market news regarding Omega-3. Curated daily for quality and relevance.
Protein, dairy, and so-called "healthy" fats are the foundational elements of the new dietary guidelines. But what is a "healthy" fat, anyway?
Read Full SynopsisWhat you eat after a workout is just as important as the exercise itself. From the right carbs to healthy protein, experts share what to eat after a workout.
Read Full SynopsisDUBLIN and BRIDGEWATER, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today commented on recent innovations in therapies for patients with elevated triglycerides (TG) and shared its perspective on how these developments stand to shape patient access and treatment strategies. Specifically, new therapies for these patients are likely to expand the use of existing, proven options over time, including Amarin’s VASCEPA®/VAZKEPA® (icosapent ethyl), an effective, safe, oral therapy that has been prescribed more than 25 million times to patients globally. In addition, through its approved indication for severe hypertriglyceridemia (sHTG), which is defined as TG ≥500 mg/dL, as well as strong clinical evidence, affordability, and broad reimbursement, VASCEPA/VAZKEPA aligns with current payor-driven step therapy programs, which require patients to try existing safe and efficacious treatment options before newer, more expensive sHTG alternatives.
Read Full SynopsisAUSTIN, Texas and TOKYO, Jan. 9, 2026 /PRNewswire/ -- According to DataM Intelligence, the global Algae Omega-3 Ingredients Market was valued at USD 850.5 million in 2024 and is projected to reach USD 1,471.3 million by 2032, expanding at a CAGR of 7.4% during the forecast period...
Read Full SynopsisAmarin Corporation PLC (NASDAQ:AMRN – Get Free Report) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $15.89 and traded as high as $16.53. Amarin shares last traded at $16.40, with a volume of 252,670 shares changing hands. Wall Street [...]
Read Full SynopsisEating for your heart doesn't mean you have to skip dessert. Here are some of our favorite sweet treats made with nutrient-dense ingredients.
Read Full Synopsis